BETA-HAIRPIN PEPTIDOMIMETIC WITH ELASTASE INHIBITORY ACTIVITY AND AEROSOL DOSAGE FORMS THEREOF
The present invention relates to pharmaceutical aerosols comprising a β-hairpin peptidomimetic of formula cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-DPro-Pro-), or a pharmaceutically acceptable salt thereof, having inhibitory activity against human neutrophil elastase. It further relates to...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English Lithuanian |
Published |
26.09.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to pharmaceutical aerosols comprising a β-hairpin peptidomimetic of formula cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-DPro-Pro-), or a pharmaceutically acceptable salt thereof, having inhibitory activity against human neutrophil elastase. It further relates to solid or liquid pharmaceutical compositions and kits for preparing and administering such aerosols. The invention can be used for the prevention, management or treatment of pulmonary diseases, such as alpha-1 antitrypsin deficiency (AATD), cystic fibrosis (CF), non-cystic fibrosis bronchiactasis (NCFB), or chronic obstructive pulmonary disease (COPD), or infections, or diseases, or conditions of the lungs, being mediated by or resulting from human neutrophil elastase activity. Thus, the invention further relates to a pharmaceutical composition or a pharmaceutical aerosol comprising the active compound cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-DPro-Pro-), or any pharmaceutically acceptable salt thereof, for use in a method for the prevention, management or treatment of diseases or conditions of the lungs being mediated by or resulting from human neutrophil elastase activity in a subject. |
---|---|
AbstractList | The present invention relates to pharmaceutical aerosols comprising a β-hairpin peptidomimetic of formula cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-DPro-Pro-), or a pharmaceutically acceptable salt thereof, having inhibitory activity against human neutrophil elastase. It further relates to solid or liquid pharmaceutical compositions and kits for preparing and administering such aerosols. The invention can be used for the prevention, management or treatment of pulmonary diseases, such as alpha-1 antitrypsin deficiency (AATD), cystic fibrosis (CF), non-cystic fibrosis bronchiactasis (NCFB), or chronic obstructive pulmonary disease (COPD), or infections, or diseases, or conditions of the lungs, being mediated by or resulting from human neutrophil elastase activity. Thus, the invention further relates to a pharmaceutical composition or a pharmaceutical aerosol comprising the active compound cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-DPro-Pro-), or any pharmaceutically acceptable salt thereof, for use in a method for the prevention, management or treatment of diseases or conditions of the lungs being mediated by or resulting from human neutrophil elastase activity in a subject. |
Author | KELLER, Manfred LUDIN, Christian |
Author_xml | – fullname: LUDIN, Christian – fullname: KELLER, Manfred |
BookMark | eNqNyj0KwkAQQOEttPDvDnOBgBiRtJNk1h1IMmF3UGwMQdZKkkC8P1p4AKv3FW9tFsM4xJW556SYOGTfcgMttcql1FyTcgFXVgdUYVAMBNw4zlnF3wAL5QvrF00JSF6CVFBKwDOBFV8HUEeexG7N8tm_5rj7dWPAkhYuidPYxXnqH3GI767S9HhKD9leNf1j-QAsGTT9 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | BETA PLAUKŲ SEGTUKO STRUKTŪROS PEPTIDO MIMETIKAS, PASIŽYMINTIS ELASTAZĖS SLOPIKLIO AKTYVUMU IR JO AEROZOLINĖS VAISTO FORMOS |
ExternalDocumentID | LT3463280TT |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_LT3463280TT3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:46:35 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Lithuanian |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_LT3463280TT3 |
Notes | Application Number: LTEP2017025156T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220926&DB=EPODOC&CC=LT&NR=3463280T |
ParticipantIDs | epo_espacenet_LT3463280TT |
PublicationCentury | 2000 |
PublicationDate | 20220926 |
PublicationDateYYYYMMDD | 2022-09-26 |
PublicationDate_xml | – month: 09 year: 2022 text: 20220926 day: 26 |
PublicationDecade | 2020 |
PublicationYear | 2022 |
RelatedCompanies | Spexis AG |
RelatedCompanies_xml | – name: Spexis AG |
Score | 3.4214253 |
Snippet | The present invention relates to pharmaceutical aerosols comprising a β-hairpin peptidomimetic of formula... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | BETA-HAIRPIN PEPTIDOMIMETIC WITH ELASTASE INHIBITORY ACTIVITY AND AEROSOL DOSAGE FORMS THEREOF |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220926&DB=EPODOC&locale=&CC=LT&NR=3463280T |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFA9zinrTqTi_yEF6K9asa7fDkH6kNNI2pY1zXhTbZijINlzFf9-XsqkXvT0SeCSP_JL3HYQue2VBhv2BoZNC2rppSsCcKfv61C4lHCeVFqD8HXFihXfm7aQ_aaGXdS1M0yf0s2mOCIgqAe91c18vfpxYfpNbubwqXmFofhOIka-trGNCjCGxNN8d0ZT73NM8bxQJLcngsrZ6ZGCIDbQJSrStsEDHrqpJWfx-UII9tJUCr1m9j1pvdQfteOt_1zpoO16Fu4FcIW95gB5dKhw9dFgGdjhOaSqYz2MWU8E8fM9EiGnk5MLJKWZJyFwmePaAVYrImAkgEh87NOM5j7DPVRgJg_kX51iENKM8OEQ4oMILdVjo07dMniKx3pHoHaH2bD6TxwhLSUxZGVNTlYzaFSmM50rK6wp0pqIw7bKLun-yOfln7hTtKuGqPAlinaF2_f4hz-ExrouLRo5fk4CHwA |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH_MKc6bTsX5mYP0VqxZ126HIf1IabRftHHOi8O2GQqyDVfx3zcpm3rR2yOBR_LIL3nfAbjsFjke9PqainNuqrrOBeZ03lOnZsHFcZJpAdLfEUaGf6_fjnvjBrysa2HqPqGfdXNEgahC4L2q7-vFjxPLrXMrl1f5qxia33hs6Cor6xhjbYANxbWHJInd2FEcZxgwJUrFZW10cV9jG7ApFGxTYoGMbFmTsvj9oHi7sJUIXrNqDxpvVRtazvrftTZsh6twtyBXyFvuw5NNmKX6Fk2FHY4SkjDqxiENCaMOeqDMRySwMmZlBNHIpzZlcfqIZIrIiDJBRC6ySBpncYDcWIaRkDD_wgwxn6Qk9g4AeYQ5vioWOvmWySRg6x2x7iE0Z_MZPwLEOdZ5qU11WTJqljjXnkvOr0uhM-W5bhYd6PzJ5vifuQto-SwMJgGN7k5gRwpa5kxg4xSa1fsHPxMPc5Wf1zL9Ah2rirM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BETA-HAIRPIN+PEPTIDOMIMETIC+WITH+ELASTASE+INHIBITORY+ACTIVITY+AND+AEROSOL+DOSAGE+FORMS+THEREOF&rft.inventor=LUDIN%2C+Christian&rft.inventor=KELLER%2C+Manfred&rft.date=2022-09-26&rft.externalDBID=T&rft.externalDocID=LT3463280TT |